Design, synthesis, and characterization of a highly effective Hog1 inhibitor: A powerful tool for analyzing map kinase signaling in yeast

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Dinér, Peter ^a   Veide Vilg, Jenny ^a   Kjellén, Jimmy ^a   Migdal, Iwona ^b   Andersson, Terese ^a   Gebbia, Marinella ^c   Giaever, Guri ^c   Nislow, Corey ^c   Hohmann, Stefan ^a   Wysocki, Robert ^b   Tamás, Markus J ^a   Grøtli, Morten ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF WROC AW   (Poland)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; GLYCEROL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; ENZYME INHIBITOR; HOG1 PROTEIN, S CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEIN;

ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL MEMBRANE PERMEABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; TRANSPORT KINETICS; WILD TYPE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; SYNTHESIS;

SACCHAROMYCES CEREVISIAE;

ENZYME INHIBITORS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION;

EID: 79957788651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020012     Document Type: Article

References (47)

1. Goldstein DM, Gray NS, Zarrinkar PP, (2008) High-throughput kinase profiling as a platform for drug discovery. Nature Reviews Drug Discovery 7: 391-397.
2. Specht KM, Shokat KM, (2002) The emerging power of chemical genetics. Current Opinion in Cell Biology 14: 155-159.
3. Noble MEM, Endicott JA, Johnson LN, (2004) Protein kinase inhibitors: Insights into drug design from structure. Science 303: 1800-1805.
4. Davies SP, Reddy H, Caivano M, Cohen P, (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochemical Journal 351: 95-105.
5. Bishop AC, Ubersax JA, Petsch DT, Matheos DP, Gray NS, et al. (2000) A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 407: 395-401.
6. Knight ZA, Shokat KM, (2007) Chemical Genetics: Where Genetics and Pharmacology Meet. Cell 128: 425-430.
7. Kim S, Shah K, (2007) Dissecting yeast Hog1 MAP kinase pathway using a chemical genetic approach. Febs Letters 581: 1209-1216.
8. Macia J, Regot S, Peeters T, Conde N, Sole R, et al. (2009) Dynamic Signaling in the Hog1 MAPK Pathway Relies on High Basal Signal Transduction. Science Signaling 2: ra13.
9. Westfall PJ, Thorner J, (2006) Analysis of mitogen-activated protein kinase signaling specificity in response to hyperosmotic stress: Use of an analog-sensitive HOG1 allele. Eukaryotic Cell 5: 1215-1228.
10. de Nadal E, Posas F, (2010) Multilayered control of gene expression by stress-activated protein kinases. Embo Journal 29: 4-13.
11. Hohmann S, (2002) Osmotic stress signaling and osmoadaptation in Yeasts. Microbiology and Molecular Biology Reviews 66: 300-372.
12. Hohmann S, (2009) Control of high osmolarity signalling in the yeast Saccharomyces cerevisiae. Febs Letters 583: 4025-4029.
13. Westfall PJ, Patterson JC, Chen RE, Thorner J, (2008) Stress resistance and signal fidelity independent of nuclear MAPK function. Proceedings of the National Academy of Sciences of the United States of America 105: 12212-12217.
14. Thorsen M, Di Y, Tangemo C, Morillas M, Ahmadpour D, et al. (2006) The MAPK Hog1p modulates Fps1p-dependent arsenite uptake and tolerance in yeast. Molecular Biology of the Cell 17: 4400-4410.
15. Proft M, Struhl K, (2004) MAP kinase-mediated stress relief that precedes and regulates the timing of transcriptional induction. Cell 118: 351-361.
16. Bilsland-Marchesan E, Arino J, Saito H, Sunnerhagen P, Posas F, (2000) Rck2 kinase is a substrate for the osmotic stress-activated mitogen-activated protein kinase Hog1. Molecular Biology of the Cell 20: 3887-3895.
17. Clotet J, Escote X, Adrover MA, Yaakov G, Gari E, et al. (2006) Phosphorylation of Hsl1 by Hog1 leads to a G(2) arrest essential for cell survival at high osmolarity. Embo Journal 25: 2338-2346.
18. Escote X, Zapater M, Clotet J, Posas F, (2004) Hog1 mediates cell-cycle arrest in G1 phase by the dual targeting of Sic1. Nature Cell Biology 6: 997-1002.
19. Yaakov G, Duch A, Garcia-Rubio M, Clotet J, Jimenez J, et al. (2009) The Stress-activated Protein Kinase Hog1 Mediates S Phase Delay in Response to Osmostress. Molecular Biology of the Cell 20: 3572-3582.
20. Migdal I, Ilina Y, Tamás MJ, Wysocki R, (2008) Mitogen-activated protein kinase Hog1 mediates adaptation to G1 checkpoint arrest during arsenite and hyperosmotic stress. Eukaryotic Cell 7: 1309-1317.
21. Goldstein DM, Kuglstatter A, Lou Y, Soth MJ, (2009) Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders. Journal of Medicinal Chemistry 53: 2345-2353.
22. Cuenda A, Rousseau S, (2007) p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 1773: 1358-1375.
23. Kim JY, Choi JA, Kim TH, Yoo YD, Kim JI, et al. (2002) Involvement of p38 mitogen-activated protein kinase in the cell growth inhibition by sodium arsenite. Journal of Cellular Physiology 190: 29-37.
24. Li JP, Yang JL, (2007) Cyclin B1 proteolysis via p38 MAPK signaling participates in G2 checkpoint elicited by arsenite. Journal of Cellular Physiology 212: 481-488.
25. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, et al. (1995) Sb-203580 Is a Specific Inhibitor of a Map Kinase Homolog Which Is Stimulated by Cellular Stresses and Interleukin-1. Febs Letters 364: 229-233.
26. Young PR, McLaughlin MM, Kumar S, Kassis S, Doyle ML, et al. (1997) Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. Journal of Biological Chemistry 272: 12116-12121.
27. Dinér P, Andersson T, Kjellen J, Elbing K, Hohmann S, et al. (2009) Short cut to 1,2,3-triazole-based p38 MAP kinase inhibitors via [3+2]-cycloaddition chemistry. New Journal of Chemistry 33: 1010-1016.
28. Schrödinger (2008) Glide [5.0] New York Schrödinger, LLC.
29. Schrödinger (2008) Macromodel [9.0] New York Schrödinger, LLC.
30. Jackson JR, Bolognese B, Hillegass L, Kassis S, Adams J, et al. (1998) Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. Journal of Pharmacology and Experimental Therapeutics 284: 687-692.
31. Wolfe JP, Tomori H, Sadighi JP, Yin JJ, Buchwald SL, (2000) Simple, efficient catalyst system for the palladium-catalyzed amination of aryl chlorides, bromides, and triflates. Journal of Organic Chemistry 65: 1158-1174.
32. Krantz M, Ahmadpour D, Ottosson LG, Warringer J, Waltermann C, et al. (2009) Robustness and fragility in the yeast high osmolarity glycerol (HOG) signal-transduction pathway. Molecular Systems Biology 5: 281.
33. Maeda T, Wurgler-Murphy SM, Saito H, (1994) A two-component system that regulates an osmosensing MAP kinase cascade in yeast. Nature 369: 242-245.
34. Balzi E, Wang M, Leterme S, Vandyck L, Goffeau A, (1994) Pdr5, a Novel Yeast Multidrug-Resistance Conferring Transporter Controlled by the Transcription Regulator Pdr1. Journal of Biological Chemistry 269: 2206-2214.
35. Wurgler-Murphy SM, Maeda T, Witten EA, Saito H, (1997) Regulation of the Saccharomyces cerevisiae HOG1 mitogen-activated protein kinase by the PTP2 and PTP3 protein tyrosine phosphatases. Molecular Cell Biology 17: 1289-1297.
36. Rep M, Krantz M, Thevelein JM, Hohmann S, (2000) The Transcriptional Response of Saccharomyces cerevisiae to Osmotic Shock. Journal of Biological Chemistry 275: 8290-8300.
37. Rudolf F, Pelet S, Peter M, (2008) Regulation of MAPK Signaling in Yeast; In: Posas F, Nebrada AR, editors. Springer Berlin/ Heidelberg pp. 187-204.
38. O'Rourke SM, Herskowitz I, (1998) The Hog1 MAPK prevents cross talk between the HOG and pheromone response MAPK pathways in Saccharomyces cerevisiae. Genes & Development 12: 2874-2886.
39. Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, et al. (2010) The genetic landscape of a cell. Science 327: 425-431.
40. Tong AH, Lesage G, Bader GD, Ding H, Xu H, et al. (2004) Global mapping of the yeast genetic interaction network. Science 303: 808-813.
41. Reiser V, Ruis H, Ammerer G, (1999) Kinase Activity-dependent Nuclear Export Opposes Stress-induced Nuclear Accumulation and Retention of Hog1 Mitogen-activated Protein Kinase in the Budding Yeast Saccharomyces cerevisiae. Molecular and Cellular Biology 10: 1147-1161.
42. Warringer J, Blomberg A, (2003) Automated screening in environmental arrays allows analysis of quantitative phenotypic profiles in Saccharomyces cerevisiae. Yeast 20: 53-67.
43. Amberg D, Burke D, Strathern J, (2005) Methods in Yeast Genetics: A Cold Spring Harbor Laboratory Course Manual New York Cold Spring Harbor Laboratory Press.
44. de Nadal E, Casadome L, Posas F, (2003) Targeting the MEF2-Like Transcription Factor Smp1 by the Stress-Activated Hog1 Mitogen-Activated Protein Kinase. Molecular and Cellular Biology 23: 229-237.
45. Hutti JE, Jarrell ET, Chang JD, Abbott DW, Storz P, et al. (2004) A rapid method for determining protein kinase phosphorylation specificity. Nature Methods 1: 27-29.
46. Ericson E, Gebbia M, Heisler LE, Wildenhain J, Tyers M, et al. (2008) Off-target effects of psychoactive drugs revealed by genome-wide assays in yeast. PLoS Genetics 4: e1000151.
47. Pierce SE, Davis RW, Nislow C, Giaever G, (2007) Genome-wide analysis of barcoded Saccharomyces cerevisiae gene-deletion mutants in pooled cultures. Nature Protocols 2: 2958-2974.